Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 16 X posts from 13 X users, with an upper bound of 104,735 followers.

RT @DrImranSheikh: Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surge…

RT @NCI_Bogler: Check out the recent Front Immunol paper with @theNCI fellow Dr. Vasiliki Stravokefalou in @NCIResearchCtr VB https://t.co/…

RT @NCI_Bogler: Check out the recent Front Immunol paper with @theNCI fellow Dr. Vasiliki Stravokefalou in @NCIResearchCtr VB https://t.co/…

Check out the recent Front Immunol paper with @theNCI fellow Dr. Vasiliki Stravokefalou in @NCIResearchCtr VB https://t.co/m7bxWXQ1zw on hetIL-15 improving chemo & surgery in TNBC model. Congrats! #NCIFuture #CancerTraining https://t.co/9lWAT5vruW http

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.